IDEXX files Form 144 for 1,758 common shares

IDEXX Laboratories reported a proposed sale of 1,758 common shares via Form 144, listed with Morgan Stanley Smith Barney LLC as the broker on 03/03/2026.

Rhea-AI Filing Summary

IDEXX Laboratories reported a proposed sale of 1,758 common shares via Form 144, listed with Morgan Stanley Smith Barney LLC as the broker on 03/03/2026.

The shares are labeled as exercised shares with an exercise date of 08/06/2025. The excerpt also shows prior sales of 2,693 common shares on 02/25/2026 with an aggregate dollar amount of 1,781,530.72.

Insights

Securities Attorney

Form 144 notifies the market of a planned brokered sale of insider-held shares.

This excerpt lists 1,758 common shares proposed for sale through Morgan Stanley Smith Barney LLC and labels them as exercised shares with an exercise date of 08/06/2025. The filing date appears as 03/03/2026.

It also records prior dispositions of 2,693 common shares on 02/25/2026 for 1,781,530.72. Timing and final execution depend on broker handling and compliance with Section 16/Rule 144 transfer mechanics; subsequent filings will show completed transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for IDXX report?

It reports a proposed sale of 1,758 common shares filed with a broker on 03/03/2026. The filing lists the shares as exercised shares with exercise date 08/06/2025.

Who is the broker listed on the IDXX Form 144?

The broker shown is Morgan Stanley Smith Barney LLC at 1 New York Plaza. The broker entry appears alongside the 1,758-share proposed sale recorded on 03/03/2026.

Were there recent insider sales disclosed for IDXX?

Yes; the excerpt shows prior sales of 2,693 common shares on 02/25/2026 with aggregate proceeds of 1,781,530.72, as reported in the filing excerpt.

What type of shares are being offered in the Form 144?

The filing labels the securities as Common and specifically as exercised shares with an exercise date of 08/06/2025, per the excerpt.

Does the Form 144 show who is selling the shares for IDXX?

The excerpt names NIMRATA K HUNT and lists Morgan Stanley Smith Barney LLC as the broker; the filing ties the proposed sale to those entries in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:08 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001800619
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IDEXX LABORATORIES, INC.
SEC File Number	000-19271
Address of Issuer	One IDEXX Drive Westbrook MAINE 04092
Phone	207-556-0300
Name of Person for Whose Account the Securities are To Be Sold	NIMRATA K HUNT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1758	1115577.22	79624034	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/06/2025	Exercised Shares	Issuer			1758	08/06/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NIMRATA K HUNT One IDEXX Drive Westbrook ME 04092	Common	02/25/2026	2693	1781530.72

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nimrata K. Hunt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)